Intragastric Balloons Market Forecast to Reach USD 160.7 Million by 2031, Backed by Increasing Obesity Prevalence and Preference for Minimally Invasive Treatments - Transparency Market Research

The global intragastric balloons market, valued at US$ 55.5 million in 2022, is poised for significant growth. Projections indicate that the market will advance at a compound annual growth rate (CAGR) of 12.2% from 2023 to 2031, reaching US$ 160.7 million by the end of the forecast period.

Gain a preview of important insights from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=26006

The rising prevalence of obesity worldwide is a primary driver of market growth. Increased adoption of intragastric balloons by both patients and physicians is noted due to their clinically proven efficacy, minimal risk, and rapid recovery time. The demand for minimally invasive weight-loss therapies is further bolstering the market, as these devices offer an attractive alternative to surgical procedures. Technological advancements-such as volume-adjustable and swallowable balloon designs-present lucrative opportunities for market players aiming to enhance cost efficiency and clinical outcomes.

Market Introduction

Intragastric balloons, also known as stomach or gastric balloons, are medical devices temporarily placed in the stomach to induce weight loss. By occupying space, they help patients feel full sooner, thereby reducing food intake and aiding in weight management. Typically implanted endoscopically and filled with saline for a duration of approximately six months, these devices have demonstrated the potential to facilitate a 15% to 25% reduction in body weight when combined with lifestyle modifications.

Rise in Prevalence of Obesity Globally Propelling Market Growth

The global obesity epidemic has surged over recent decades. According to the World Health Organization, obesity rates have nearly tripled since 1975-with over 1.9 billion adults overweight and more than 650 million classified as obese as of 2016. This alarming trend is driving demand for effective, non-invasive weight-loss interventions, such as intragastric balloons, which are increasingly recognized as both a preliminary and alternative therapy for weight management.

Increase in Demand for Minimally Invasive Weight-loss Therapies

Growing awareness about the health risks associated with obesity is leading more patients and healthcare providers to favor minimally invasive weight-loss procedures. Intragastric balloons offer a safe, outpatient solution with minimal downtime, reducing the need for extensive lifestyle changes or invasive surgery. This approach has seen rising popularity, especially among individuals seeking rapid yet sustainable weight reduction without the complexities of bariatric surgery.

Proven Safety Record Driving Demand for Fluid-filled Balloons

Fluid-filled intragastric balloons have established a dominant market presence due to their long history of clinical use and proven safety profile. With a lower risk of complications compared to gas-filled alternatives, fluid balloons offer a cost-effective solution that is easier to mass produce and administer, particularly in regions where affordability and ease of use are paramount.

Easy Access and Personalized Attention Fueling Demand for Ambulatory Surgical Centers

Ambulatory surgical centers (ASCs) have emerged as the preferred end-user for intragastric balloon procedures. ASCs offer the advantages of planned, same-day procedures with personalized patient care, reduced hospital-acquired infection risks, and overall cost efficiency. Their streamlined operations make them ideal for managing the growing demand for weight-loss therapies among overweight and obese populations.

Access our report for a comprehensive look at key insights - https://www.transparencymarketresearch.com/intragastric-balloons-market.html

Regional Outlook

North America: Dominates the global intragastric balloons market due to favorable demographics, advanced healthcare infrastructure, and robust reimbursement systems such as Medicare supporting minimally invasive procedures.

Europe: Benefits from high levels of obesity awareness and a proactive approach to preventive healthcare, reinforcing its strong market position.

Asia Pacific: Expected to witness rapid growth driven by a large patient population, rising healthcare standards, and increasing awareness about obesity management, particularly in countries like India and China.

Analysis of Key Players
The market is consolidated among a few key players who are investing heavily in research and development to expand their product portfolios. Leading companies include Apollo Endosurgery, Inc., ReShape Lifesciences, Inc., Spatz FGIA, Inc., Allurion S.a.s., ENDALIS, Helioscopie, LEXEL S.R.L., and CSC MEDSIL. These players are leveraging collaborations, strategic partnerships, and mergers & acquisitions to maintain and enhance their market share.

Key Developments in Global Intragastric Balloons Market

October 2023: Spatz Medical received FDA approval for its Spatz3 Gastric Balloon-the first adjustable gastric balloon system. Clinical trials revealed a 15% weight reduction and an 84% success rate, with nearly 100,000 patients across over 40 countries benefiting from its innovative adjustability.

June 2023: Allurion signed a 12-month pilot collaboration agreement with Medtronic to distribute its swallowable gastric balloon alongside an AI-driven platform for weight loss management. This balloon, designed to remain in place for about four months, is integrated with a connected scale, health-tracking smartwatch, and mobile app to provide comprehensive patient monitoring and guidance.

April 2023: Boston Scientific completed the acquisition of Apollo Endosurgery for approximately US$ 615 million. This strategic move expands Boston Scientific's portfolio in endoluminal surgery, offering less-invasive alternatives to conventional bariatric procedures.

Market Segmentation

Duration: 6 Months

Type: Fluid-filled Balloons, Gas-filled Balloons

Administration: Endoscopy, Swallowable

End-user: Hospitals, Ambulatory Surgical Centers, Specialty Clinics

Regions Covered: North America, Europe, Asia Pacific, Latin America, Middle East & Africa

A Market Poised for Expansion

The intragastric balloons market is positioned for substantial growth, driven by the global obesity epidemic, the shift toward minimally invasive procedures, and ongoing technological advancements. With supportive healthcare infrastructure developments and increasing patient preference for less invasive weight-loss solutions, the market offers promising opportunities for both established players and new entrants.

Why This Report Matters?

Comprehensive Insights: Provides detailed analysis of market segmentation, regional trends, and competitive dynamics.

Informed Decision-Making: Equips stakeholders with critical information to guide strategic planning and investment decisions.

Innovation Focus: Highlights technological advancements and emerging trends that are reshaping the weight-loss therapy landscape.

Growth Drivers: Identifies key factors such as rising obesity rates and the demand for minimally invasive procedures.

Risk Awareness: Outlines challenges such as regulatory concerns and technological limitations to help mitigate potential risks.

The Future of Intragastric Balloons

The future of the intragastric balloons market is set to be defined by continuous innovation and enhanced clinical outcomes. As technological advancements lead to more customizable, safe, and effective balloon designs-such as adjustable and swallowable options-the market is expected to play a pivotal role in non-surgical weight management. Moreover, increased adoption of these devices by ambulatory surgical centers and the integration of digital health technologies will further drive market growth and patient satisfaction.

Examine key highlights and takeaways from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=26006

Frequently Asked Questions

Q1: What are intragastric balloons?
A: Intragastric balloons are temporary, minimally invasive medical devices inserted into the stomach to induce weight loss by occupying space, thereby helping patients feel full sooner and reduce food intake.

Q2: What factors are driving market growth?
A: Market growth is driven by the global rise in obesity, the proven efficacy and safety of intragastric balloons, technological innovations, and the increasing demand for minimally invasive weight-loss therapies.

Q3: Which regions are expected to dominate the market?
A: North America currently leads the market, with Europe and Asia Pacific also showing strong growth due to favorable healthcare infrastructure, increasing obesity prevalence, and rising awareness of weight management solutions.

Q4: How are technological advancements impacting the market?
A: Innovations such as adjustable, volume-controlled, and swallowable balloons are enhancing treatment efficacy, reducing procedural risks, and improving patient outcomes, thereby propelling market expansion

Explore Latest Research Reports by Transparency Market Research:

Heart Pumps Market - https://www.transparencymarketresearch.com/heart-pump-devices-market.html

Ingestible Sensors Market - https://www.transparencymarketresearch.com/ingestible-sensors-market.html

Ureteral Stents Market - https://www.transparencymarketresearch.com/ureteral-stents-market.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube

This release was published on openPR.